Similar drugsTo uncover
Dosage form: & nbsp

Tablets for resorption (orange, lemon, strawberry, mint).

Composition:

Active components: tirotricin 1 mg, benzocaine 2 mg

Auxiliary components:

orange

xylitol, povidone K25, povidone K90, magnesium stearate, dye sunset yellow

(E110), orange flavoring.

lemon

xylitol, povidone K90, magnesium stearate, dye quinoline yellow (E104), flavoring lemon.

strawberry

xylitol, povidone K90, magnesium stearate, dye crimson [Ponso 4R] (E124), flavoring

strawberry additive

mint

xylitol, povidone K90, magnesium stearate, dye green (E142), peppermint flavor.

Description:

orange

round tablets with a facet of a pinkish-orange color with patches. On one side

tablet engraving: "RAFA"and the image of an umbrella." The smell is orange.

lemon

Round tablets with a bevel of yellow color with impregnations. On one side of the tablet is an engraving: "RAFA"and the image of an umbrella. strawberry

round tablets with a bevel of pink and crimson color with interspersed. On one side of the tablet is an engraving: "RAFA"and the image of an umbrella.

mint

Round tablets with a green bevel with interspersed. On one side of the tablet is an engraving: "RAFA "and an image of an umbrella.

Pharmacotherapeutic group:Antiseptic + local anesthetic
Pharmacodynamics:

Combined drug, has antiseptic and local anesthetic effect. Reduces irritation and pain in the throat, as well as swelling of the oral mucosa. Benzocaine - local anesthetic for superficial anesthesia. Reduces the permeability of the cell membrane for sodium, displaces calcium from receptors located on the inner surface of the membrane, blocks the conduct of nerve impulses. When applied to the surface of the oral mucosa, the effect develops after 1 min. Tirotricin is an antibiotic obtained from bacteria of the species Bacillus brevis; is a mixture of cyclic and linear (aliphatic) polypeptides. The mixture contains up to 70-80% of tyrocidin (alkaline cyclic decapeptide) and 20-30% of gramicidin (neutral linear pentadecapeptide). It is active against a wide range of gram-positive microorganisms and spirochaetes of the oral cavity.

Indications:

Infectious and inflammatory diseases of the oral cavity and throat (symptomatic therapy).

Contraindications:

Hypersensitivity to any component included in the preparation.

Children's age (up to 18 years).

Pregnancy and lactation.

Do not apply to patients of both sexes when planning a pregnancy.

Dosing and Administration:

1 tablet every 2-3 hours. The tablet should be slowly resorbed in the mouth. Duration of treatment should not exceed 5 days.

Side effects:

Allergic reactions, contact dermatitis, persistent decrease in sensitivity of the oral mucosa. Skin rash, swelling of the oral mucosa or pharynx. If these symptoms appear, stop taking the medication and consult a doctor.

Overdose:Symptoms: cyanosis, dyspnea, dizziness. Treatment is symptomatic.
Interaction:

Benzocaine due to the formation of its metabolite 4-aminobenzoic acid reduces the antibacterial activity of sulfonamides and aminosalicylates.

Special instructions:

If there is no effect within two days, you should consult a doctor. The drug does not contain sugar, so it can be used in patients with concomitant diabetes.

Effect on the ability to drive transp. cf. and fur:There is no information.
Form release / dosage:

Lozenges.

Packaging:

For 12 tablets in a blister of PVC / aluminum foil.

2 blisters in a cardboard box with instructions for use.

Storage conditions:

Store at a temperature of no higher than 25 ° C in a dry place.

Keep out of the reach of children.

Shelf life:

3 years.

Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe
Registration number:LSR-010760/09
Date of registration:29.12.2009
The owner of the registration certificate:Rafa Laboratories LtdRafa Laboratories Ltd Israel
Manufacturer: & nbsp
Representation: & nbspRABBAYS LABORATORY LIMITEDRABBAYS LABORATORY LIMITED
Information update date: & nbsp09.12.2013
Illustrated instructions
    Instructions
    Up